Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Current Leases: 2020-2025

Historic Current Leases for Anaptysbio (ANAB) over the last 5 years, with Sep 2025 value amounting to $2.0 million.

  • Anaptysbio's Current Leases rose 8.11% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 8.11%. This contributed to the annual value of $1.9 million for FY2024, which is 8.33% up from last year.
  • Latest data reveals that Anaptysbio reported Current Leases of $2.0 million as of Q3 2025, which was up 1.95% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Current Leases peaked at $2.0 million during Q3 2025, and registered a low of $555,000 during Q2 2021.
  • Its 3-year average for Current Leases is $1.9 million, with a median of $1.9 million in 2024.
  • Data for Anaptysbio's Current Leases shows a peak YoY skyrocketed of 340.06% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Anaptysbio's Current Leases stood at $1.5 million in 2021, then rose by 8.77% to $1.6 million in 2022, then increased by 8.55% to $1.8 million in 2023, then grew by 8.33% to $1.9 million in 2024, then rose by 8.11% to $2.0 million in 2025.
  • Its Current Leases stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.